Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Classification of Connective Tissues01:30

Classification of Connective Tissues

The connective tissues have different properties and functions in the human body. They are broadly categorized into proper, supporting, or fluid connective tissues.
Connective Tissue Proper
Connective tissue proper is the most abundant class of connective tissues. As its name implies, it predominantly connects different tissues in the body. Depending on the cell types, ground substance, viscosity, and fiber types in the ECM, connective tissue proper is further categorized into loose and dense.
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism.

RMD open·2023
Same author

Activation of a Latent Epitope Causing Differential Binding of Antineutrophil Cytoplasmic Antibodies to Proteinase 3.

Arthritis & rheumatology (Hoboken, N.J.)·2022
Same author

Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Arthritis & rheumatology (Hoboken, N.J.)·2022
Same author

Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA-Associated Vasculitis.

ACR open rheumatology·2021
Same author

The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.

Journal of autoimmunity·2019
Same author

Association of Pulmonary Hemorrhage, Positive Proteinase 3, and Urinary Red Blood Cell Casts With Venous Thromboembolism in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Arthritis & rheumatology (Hoboken, N.J.)·2019

Related Experiment Video

Updated: Jul 8, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

The last classification of vasculitis.

Cees G M Kallenberg1

  • 1Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. c.g.m.kallenberg@int.umcg.nl

Clinical Reviews in Allergy & Immunology
|January 4, 2008
PubMed
Summary

Classifying systemic vasculitis aids treatment and prognosis. A new algorithm combining existing criteria and patient data improves diagnostic accuracy for vasculitis, including antineutrophil-cytoplasmic-autoantibodies-associated vasculitis and polyarteritis nodosa.

Related Experiment Videos

Last Updated: Jul 8, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Systemic vasculitides encompass diverse conditions involving blood vessel inflammation.
  • Accurate classification is crucial for homogeneous clinical characteristics, prognosis, and treatment response.
  • Current classification systems, including American College of Rheumatology (ACR) criteria and Chapel Hill definitions, often lead to overlapping diagnoses, especially in small vessel vasculitis and polyarteritis nodosa (PAN).

Purpose of the Study:

  • To evaluate a novel algorithm for classifying antineutrophil-cytoplasmic-autoantibodies-associated vasculitides and PAN.
  • To assess the utility of integrating clinical data and serological findings into classification schemes.
  • To propose a more unifying approach to classifying primary systemic vasculitides.

Main Methods:

  • Development of a new algorithm incorporating Chapel Hill definitions and ACR criteria.
  • Inclusion of clinical data and serological findings in the algorithm.
  • Evaluation of the algorithm's performance in correctly classifying patients with vasculitis.

Main Results:

  • The developed algorithm demonstrated usefulness in correctly classifying patients with antineutrophil-cytoplasmic-autoantibodies-associated vasculitides and PAN.
  • The algorithm integrates key aspects of existing criteria with patient-specific data.
  • Combining this algorithm with large vessel vasculitis definitions offers a more unified classification approach.

Conclusions:

  • A novel algorithm integrating clinical and serological data improves classification accuracy for specific vasculitides.
  • This approach addresses limitations of existing classification schemes, such as diagnostic overlap.
  • Further application of this algorithm, alongside large vessel vasculitis definitions, may lead to a more unified system for primary systemic vasculitides.